Bauchart-Thevret C, Cui L, Wu G, Burrin DG. Arginineinduced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide. Am J Physiol Endocrinol Metab 299: E899 -E909, 2010. First published September 14, 2010; doi:10.1152/ajpendo.00068.2010.-Arginine is an indispensable amino acid in neonates and is required for growth. Neonatal intestinal epithelial cells (IEC) are capable of arginine transport, catabolism, and synthesis and express nitric oxide (NO) synthase to produce NO from arginine. Our aim was to determine whether arginine directly stimulates IEC growth and protein synthesis and whether this effect is mediated via mammalian target of rapamycin (mTOR) and is NOdependent. We studied neonatal porcine IEC (IPEC-J2) cultured in serum-and arginine-free medium with increasing arginine concentrations for 4 or 48 h. Our results show that arginine enhances IPEC-J2 cell survival and protein synthesis, with a maximal response at a physiological concentration (0.1-0.5 mM). Addition of arginine increased the activation of mTOR, p70 ribosomal protein S6 (p70 S6) kinase, and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) in a time-and dose-dependent manner. The arginine-induced protein synthesis response was not inhibited by the NO inhibitors nitro-Larginine methyl ester (L-NAME) and aminoguanidine, despite inducible NO synthase expression in IPEC-J2 cells. Moreover, protein synthesis was not increased or decreased in some cases by addition of an NO donor (S-nitroso-N-acetylpenicillamine), arginine precursors (proline and citrulline) in the absence of arginine, or insulin; Snitroso-N-acetylpenicillamine suppressed phosphorylation of mTOR, p70 S6 kinase, and 4E-BP1. We found a markedly higher arginase activity in IPEC-J2 cells than in primary pig IEC. Furthermore, mTOR inhibition by rapamycin partially (42%) reduced the arginineinduced protein synthesis response and phosphorylation of mTOR and 4E-BP1. We conclude that arginine-dependent cell survival and protein synthesis signaling in IPEC-J2 cells are mediated by mTOR, but not by NO. cell growth; p70 ribosomal protein S6 kinase; eukaryotic initiation factor 4E-binding protein 1; rapamycin; S-nitroso-N-acetylpenicillamine
cell growth; p70 ribosomal protein S6 kinase; eukaryotic initiation factor 4E-binding protein 1; rapamycin; S-nitroso-N-acetylpenicillamine ARGININE IS AN INDISPENSABLE amino acid in neonatal mammals and is required for somatic growth (39) . Arginine is also a physiological precursor for nitric oxide (NO), a molecule that has several critical functions in the body, including vasodilatation, immune responses, neurotransmission, and cell survival (43) . Thus, beyond its role in protein deposition, it is likely that arginine is nutritionally essential for other important functions in infants, particularly in the intestine. Although arginine synthesis in adult mammals occurs via the intestinal-renal axis (43) , the neonatal intestine contains all the enzymes necessary to synthesize arginine (20, 37, 41) , and the small intestine is a key site of net arginine synthesis in neonates (39, 42, 43) . Thus the gut appears to play a critical role in maintaining arginine homeostasis in neonates (13, 40) .
Evidence from in vitro metabolic studies with primary cells and transformed cell lines indicates that intestinal epithelial cells (IEC) are capable of arginine transport, catabolism, and synthesis from precursor amino acids, such as citrulline (3, 29, 38, 43) . However, studies also showed that increasing extracellular arginine in vitro and in vivo stimulates anabolic cell pathways, such as protein synthesis, proliferation, and migration (6, 25, 26, 32) . Arginine supplementation stimulated protein synthesis and reduced protein degradation in LPStreated IPEC-1 cells (32) . Studies in preconfluent Caco-2 cells suggest that arginine deprivation decreases cell proliferation and heat shock protein expression and enhances the susceptibility to apoptosis, and most changes induced by arginine deficiency were restored by subsequent supplementation with arginine or citrulline (22) . The essentiality of arginine for cell growth is mainly due to its role as a constituent amino acid for protein synthesis in cells where arginine synthesis is negligible. However, recent studies also suggest that arginine may directly activate anabolic cellular signaling pathways (6, 32, 44) .
One of the major amino acid-responsive signaling pathways involved in cell growth is mammalian target of rapamycin (mTOR) (11) . mTOR is a highly conserved serine/threonine protein kinase that controls many aspects of cellular physiology, including protein synthesis (7, 15) . mTOR is a common signaling complex that mediates the cellular anabolic responses to insulin and amino acids; yet, among the amino acids, leucine and arginine are the most potent activators (16) . Few studies have examined the amino acid activation of mTOR signaling in IEC. However, recent studies in rat IEC showed that arginine and leucine stimulate downstream targets of mTOR, namely, p70 ribosomal protein S6 (p70 S6) kinase and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), and this response was inhibited by glutamine (2, 24) . Consistent with the cell culture finding, a study in rotavirus-infected piglets showed that dietary arginine treatment increased intestinal protein synthesis in association with activation of mTOR and p70 S6 kinase signaling (6) . Thus the emerging evidence suggests that arginine increases IEC growth and protein synthesis via activation of mTOR pathways.
A major unresolved issue regarding mTOR function is the nature of the cell-sensing mechanism and upstream signals that are activated by amino acids, specifically arginine. Nitric oxide (NO) is the major cell signaling molecule and product of arginine metabolism via NO synthases (NOS). The three forms of NOS, namely, endothelial NOS (eNOS), neuronal NOS, and inducible NOS (iNOS), are differentially expressed in the cells within the intestine, including epithelial cells (21) . A recent study in cdx2-transformed rat crypt IEC-6 cells showed that arginine stimulated cell migration via a mechanism requiring NO and phosphorylation of p70 S6 kinase (26) . It is unknown whether the arginine-mediated activation of protein synthesis and mTOR is NO-dependent. In the present study, we hypothesize that arginine directly stimulates IEC growth and protein synthesis via NO-dependent activation of the mTOR signaling pathway. We tested this hypothesis using an established IEC line derived from neonatal pigs by culturing cells with increasing arginine concentrations in the presence of inhibitors of NOS and mTOR.
MATERIALS AND METHODS
Cell culture and treatment. The IPEC-J2 cell line, a porcine IEC line originally derived from the jejunal crypts of a neonatal piglet, was kindly supplied by Bruce Shultz (Kansas State University). The cells were seeded in six-well plates and grown in DMEM (catalog no. 11965, GIBCO, Carlsbad, CA) added with 10% (vol/vol) FBS (Hyclone, Logan, UT) and maintained at 37°C in a 5% CO 2 atmosphere. All the experiments were performed in duplicate or triplicate on cell passages 39 -56 .
For the cell growth response, the cells were grown to 50% confluence in regular growth DMEM containing 10% FBS and then changed to a serum-and arginine-free custom-made DMEM (modified DMEM 21013, GIBCO) that contained (mM) 5.0 D-glucose, 0.4 cysteine·HCl·H 2O, 0.5 glutamine, 0.4 glycine, 0.2 histidine·HCl·H2O, 0.8 isoleucine, 0.8 leucine, 0.8 lysine·HCl, 0.4 phenylalanine, 0.4 serine, 0.8 threonine, 0.1 tryptophan, 0.4 tyrosine·2Na·2H 2O, and 0.8 valine. Cells were treated for 2 days with 1) arginine (0 -1 mM) added with 0.2 mM methionine; 2) methionine (0 or 0.5 mM) added with 0.5 mM arginine; or 3) arginine (0 or 0.5 mM) and rapamycin, an mTOR inhibitor (0 or 10 nM) added with 0.2 mM methionine. Cell growth was determined by counting the number of cells in each well of the plates using a particle counter (model Z1, Beckman Coulter). Cellular protein and DNA content was determined using bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL) and DNA assay Hoechst reagent 33258 (Sigma, St. Louis, MO), respectively.
For cell protein synthesis response experiments and mTOR, p70 S6 kinase, and 4E-BP1 activation by immunoblot analysis, cells were grown to 80% confluence in regular growth DMEM (catalog no. 11965, GIBCO) added with 10% FBS and then changed to a serumand arginine-free custom-made DMEM (modified DMEM 21013, GIBCO) overnight prior to treatment for 1-4 h with 1) arginine (0 -1 mM) in the presence or absence of 5 g/ml insulin or 5 g/ml insulin-transferrin-sodium selenite (ITS); 2) in the presence or absence of 0.5 mM arginine and 0.2 mM methionine; 3) NO inhibitors N G -nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (0 -2,000 M) in the presence of 0.5 mM arginine; 4) NO donor S-nitroso-N-acetylpenicillamine (SNAP, 0 -1,000 M) in the absence of arginine; 5) proline or citrulline (0, 1, or 5 mM) in the absence of arginine; or 6) rapamycin (0 -1,000 nM) in the presence or absence of 0. 5 Western blot analysis. For iNOS and eNOS analysis, IPEC-J2 cells were cultivated in regular growth DMEM (catalog no. 11965, GIBCO) added with 10% FBS. IPEC-J2 cells were homogenized in 50 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM dithiothreitol, 5 mg/l phenylmethylsulfonyl fluoride, 5 mg/l aprotinin, 5 mg/l chymostatin, 5 mg/l pepstatin, and 2 mM sodium orthovanadate. The homogenate was sonicated and centrifuged at 12,000 g for 15 min at 4°C. Cell protein extracts (60 g protein; assayed using the BCA method; Pierce) were separated on a 10% denatured SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. The membrane was blocked with 5% nonfat milk in 1ϫ Tris-buffered saline (TBS) and 0.1% Tween 20 for 1 h at room temperature and then incubated with iNOS or eNOS primary antibody (rabbit polyclonal, 1:500 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) diluted in 5% nonfat milk and 1ϫ TBS-0.1% Tween 20 overnight at 4°C. After it was washed with 1ϫ TBS-0.1% Tween 20, the membrane was incubated with a secondary antibody (goat anti-rabbit IgG-horseradish peroxidase, 1:5,000 dilution; Santa Cruz Biotechnology) for 1 h at room temperature. The iNOS (130 kDa) and eNOS (140 kDa) bands were detected with an enhanced chemiluminescence detection kit (ECL Plus, Amersham Biosciences) and analyzed with ImageQuant 5.2 software (Molecular Dynamics). Pig endothelial cells were used as a control.
For mTOR, p70 S6 kinase, and 4E-BP1 activation analysis, the cells were cultivated as described above (see Cell culture and treatment). Cells were scraped from culture plates and homogenized as described above. Cell extracts (50 -100 g of protein) were separated on a 7% denatured SDS-polyacrylamide gel for mTOR and p70 S6 kinase and a 15% denatured SDS-polyacrylamide gel for 4E-BP1, as described above for iNOS and eNOS. The membranes were first incubated with phosphospecific antibodies of phosphorylated (Ser 2448 ) mTOR (human polyclonal, 1:1,000 dilution; Cell Signaling Technology, Beverly, MA), phosphorylated (Thr 421 /Ser 424 ) p70 S6 kinase (human polyclonal, 1:1,000 dilution; Cell Signaling Technology), and phosphorylated (Thr 70 ) 4E-BP1 (rat polyclonal, 1:1,000 dilution; Cell Signaling Technology), stripped in stripping buffer (Pierce) at 37°C for 15 min, washed with 1ϫ TBS-0.1% Tween 20 three times, and reprobed with the corresponding non-phospho-specific antibodies, i.e., mTOR (human polyclonal, 1:1,000 dilution; Cell Signaling Technology), p70 S6 kinase (human polyclonal, 1:1,000 dilution; Cell Signaling Technology), and 4E-BP1 (human polyclonal, 1:1,000 dilution; Bethyl Laboratories, Montgomery, TX). The activation of mTOR, p70 S6 kinase, and 4E-BP1 was determined by the band intensity of the phosphorylated form relative to the band intensity of the total protein. Western blots (Figs. 2, 3C, 5, and 7C) are the results of pooled samples from two to three experiments. All membranes were stripped and reprobed with ␣-tubulin antibody (mouse monoclonal, 1:2,000 dilution; Sigma-Aldrich) for loading control.
Arginine and total nitrite concentration. Arginine free amino acid concentration was determined in cell medium by reverse-phase HPLC of their phenylisothiocyanate derivatives, as described previously (31) . Total nitrite concentration, as an index of NO production, was determined in cell medium using a total NO/nitrate/nitrite parameter kit (R & D Systems).
Enzyme activity assay. Activities of four key arginine-metabolizing enzymes, pyrroline-5-carboxylate synthase (P5CS), argininosuccinate synthase (ASS), argininosuccinate lyase (ASL), and arginase, were determined as described previously (41) on IPEC-J2 cells and neonatal pig isolated IEC. IEC were isolated from the jejunum of four 1-wk-old neonatal pigs that had been fed liquid milk-replacer formula (Advance Liqui-Wean, Milk Specialties, Dundee, IL) using the distended intestinal sac method, as described previously (9) .
The study protocol was approved by the Animal Care 
RESULTS

Cell growth and protein synthesis responses to arginine.
In an arginine-free DMEM, IPEC-J2 cell number decreased significantly by 29% and 52% after 1 and 2 days of incubation, respectively, but returned to their original number in the presence of arginine (Fig. 1A) . On day 2, we found a significant increase in IPEC-J2 cell number (ϩ129%), cell protein (ϩ75%), and DNA content (ϩ50%) with all arginine doses and a maximal response at a physiological dose of arginine (0.1-0.5 mM; Fig. 1, A and B) . After 4 h of incubation, arginine significantly increased (ϩ76%) protein synthesis in IPEC-J2 cells, with a maximal response at 0.1-0.5 mM (Fig. 1C) . The presence of 5 g/ml insulin or 5 g/ml ITS in the culture medium did not affect the cell protein synthesis response to arginine (Fig. 1C) (Fig. 2) . Overall, a significant effect of time was found for mTOR, p70 S6 kinase, and 4E-BP1 activation when the IPEC-J2 cells were incubated with 0.5 mM arginine, with a significant increase (ϩ79%) in mTOR phosphorylated-to-total protein ratio after 4 h of incubation and a marked increase (ϩ329%) in 4E-BP1 phosphorylated-to-total protein ratio within 1 h of incubation ( Fig. 2A) . In the 1-h incubation period, there was a significant effect of arginine dose for mTOR, p70 S6 kinase, and 4E-BP1 activation (Fig .   Fig. 1 . A and B: cell growth response, i.e., cell count and protein and DNA content, to arginine in IPEC-J2 cells incubated for 2 days in arginine-free DMEM. C: protein synthesis response to arginine in IPEC-J2 cells incubated for 4 h in arginine-free DMEM in the presence or absence of 5 g/ml insulin or 5 g/ml insulin-transferrin-sodium selenite (ITS). Protein synthesis was determined by 2B). Despite this main effect of arginine dose, the phosphorylated-to-total protein ratios for mTOR, p70 S6 kinase, and 4E-BP1 were not significantly increased at any arginine dose based on Tukey's means comparison. However, the absolute abundances of phosphorylated and total proteins for mTOR, p70 S6 kinase, and 4E-BP1 were markedly increased at 0.5 mM arginine compared with 0, 0.1, and 1 mM arginine (Fig.  2B) . To examine the role of insulin, we incubated the cells with 0 or 0.5 mM arginine for 1 h in the presence or absence of insulin (5 g/ml). Insulin had no effect on mTOR, p70 S6 kinase, and 4E-BP1 activation in the presence or absence of arginine (data not shown).
Effect of methionine. To determine whether the effects observed with arginine are specific, we also examined the effect of another indispensable amino acid, methionine, on cell growth, protein synthesis, and mTOR, p70 S6 kinase, and 4E-BP1 activation in IPEC-J2 cells. A significant decrease in IPEC-J2 cell number was observed after 1 day (Ϫ40%) and 2 days (Ϫ22%) of incubation in methionine-free DMEM (Fig. 3A) . It is important to note that only methionine was removed, and 0.5 mM arginine was included. In the presence of 0.5 mM methionine, the number of IPEC-J2 cells returned to their original level after 1 day (ϩ80%) and 2 days (ϩ26%) of incubation (Fig. 3A) . Although arginine deficiency significantly decreased (Ϫ43%) protein synthesis, methionine-free DMEM had no effect on protein synthesis after 4 h of incubation in IPEC-J2 cells (Fig. 3B) . However, phosphorylated-tototal protein ratios for mTOR (Ϫ30 -37%) and p70 S6 kinase (Ϫ26%) were significantly decreased by arginine and methionine deficiency (Fig. 3C) .
Effect of NO. On the basis of immunoblotting, we found that IPEC-J2 cells mainly express iNOS, since eNOS was unde- tectable (Fig. 4A ); yet protein synthesis was not affected by the NOS inhibitors L-NAME and aminoguanidine in the presence of 0.5 mM arginine (Fig. 4B) . Moreover, addition of the NO donor SNAP in the culture medium did not significantly affect protein synthesis in the absence of arginine but tended to reduce protein synthesis, and this was significant at the highest dose (Fig. 4C) . Although the NO donor SNAP significantly increased (ϩ164%) total nitrite concentration in the medium, no difference in total nitrite concentration was observed in the presence or absence of 0.5 mM arginine in IPEC-J2 cells (Fig.  4D ). In addition, the NO donor SNAP significantly decreased p70 S6 kinase (Ϫ38%) and 4E-BP1 (Ϫ26%) phosphorylatedto-total protein ratios in IPEC-J2 cells incubated in argininefree DMEM (Fig. 5) .
Arginine metabolism in IPEC-J2 cells. Proline and citrulline, both precursors for arginine synthesis in neonatal pigs (34, 36) , did not stimulate protein synthesis in IPEC-J2 cells in the absence of arginine (Fig. 6A) . However, we found only barely detectable or no arginine in the medium when IPEC-J2 cells were incubated with added proline and citrulline in argininefree medium (Fig. 6B) . The enzyme activity of P5CS, ASS, and ASL was significantly lower in IPEC-J2 cells than in pig primary IEC, whereas arginase enzyme activity was markedly (1,270-fold) higher in IPEC-J2 cells than in pig primary IEC (Fig. 6C) .
Effect of rapamycin. In the absence of arginine, rapamycin (10 nM), an mTOR inhibitor, did not affect the protein synthesis response in IPEC-J2 cells (Fig. 7A) . However, rapamycin, even at a very low dose (1-10 nM), significantly decreased (Ϫ42%) the protein synthesis response induced by arginine (Fig. 7A) . After 2 days of incubation, rapamycin significantly decreased (Ϫ30%) IPEC-J2 cell number in the presence of arginine (Fig. 7B) . In addition, a significant main effect of rapamycin was found for mTOR and 4E-BP1 activation, with a significant decrease (Ϫ42%) in mTOR phosphorylated-tototal protein ratio in IPEC-J2 cells incubated in arginine-free DMEM in the presence of rapamycin (Fig. 7C) .
DISCUSSION
The objective of this study was to determine whether arginine directly stimulates IEC growth and protein synthesis and whether this effect is NO-dependent and mediated via the mTOR signaling pathway. The rationale for this study was based on recent in vitro and in vivo studies showing that arginine stimulates protein synthesis and p70 S6 kinase in intestinal epithelium (6, 26) . We used an established porcine IEC line (IPEC-J2) originally derived from the jejunal crypts of a neonatal piglet. Our results show that arginine enhances IPEC-J2 cell survival and protein synthesis and that the maximal response occurs at physiological concentrations (i.e., 0.1-0.5 mM arginine). We also show that arginine increases the phosphorylation of mTOR and downstream targets, i.e., p70 S6 kinase and 4E-BP1 and that the arginine-mediated protein synthesis response is partially blocked by rapamycin, an mTOR inhibitor. However, the arginine-induced protein synthesis response was not affected by NOS inhibitors, the presence of insulin, or the addition of an NO donor, suggesting that production of NO and insulin is not involved in the arginine signaling mechanism.
The trophic effects of arginine on cell growth and protein synthesis shown here in IPEC-J2 cells are comparable to those recently reported in other IEC lines (IPEC-1 and Caco-2 cells) (22, 32) . Both are consistent with in vivo studies showing that an increase in arginine availability enhances body growth and intestinal tissue protein synthesis in neonatal pigs (6, 14, 19, 46 ). An especially relevant aspect of the studies with IPEC cells in the present study and a previous study (32) is that the effects of arginine are maximal at physiological concentrations (0.1-0.5 mM) normally found in the circulating plasma of young pigs (19, 46) . Other recent IEC culture studies used higher arginine concentrations (1-4 mM) to stimulate cell migration and activate downstream mTOR signals (26) . In the present study, the increase in cell number and protein and DNA content at day 2 was mainly an effect on cell survival, rather than cell proliferation, since the number of IPEC-J2 cells returned (increased) to their original level but was not greater than the number in the presence of arginine. Arginine is a precursor for protein synthesis, and in cells that are not able to synthesize it endogenously, arginine becomes the limiting amino acid in the absence of extracellular arginine. Thus the decrease in cell number after 1 and 2 days of incubation in arginine-free medium indicates that arginine is an essential amino acid in IPEC-J2 cells. Previous reports showed that arginine is necessary for tumor cell growth (4, 35, 45) ; yet the cellular mechanisms that explain the requirement have not been established.
Our results show that the arginine-induced protein synthesis response is mediated by mTOR and associated with activation of p70 S6 kinase and 4E-BP1 in a time-and dose-dependent manner. Specifically, 0.5 mM arginine markedly increased mTOR, p70 S6 kinase, and 4E-BP1 phosphorylated and total protein abundance compared with 0.1 or 1 mM arginine. This arginine activation of downstream mTOR targets (p70 S6 kinase and 4E-BP1) involved in protein synthesis is consistent with several previous studies using IEC, including porcine IPEC-1 and cdx2-tranformed IEC-6 cells (26, 27, 32) . In addition, we also tested whether the effect of arginine on IEC protein synthesis was affected by insulin, since this is another major hormone known to activate mTOR (1, 12) . We found that insulin in the presence or absence of arginine did not affect the rate of protein synthesis or phosphorylation of downstream mTOR targets, i.e., p70 S6 kinase and 4E-BP1. Taken together, the results indicate that the arginine-induced stimulation of protein synthesis and mTOR signaling is insulin-independent in IPEC-J2 cells.
To determine whether the arginine effects on IPEC-J2 cell growth and protein synthesis are specific, we also examined the effect of another indispensable amino acid, methionine, in IPEC-J2 cells. We tested methionine, since it is often considered the first-limiting amino acid for growth in animals. Interestingly, although the cell growth response to methionine was similar to arginine, the protein synthesis response was not affected by methionine deficiency. However, the activation of mTOR, p70 S6 kinase, and 4E-BP1 was decreased similarly by arginine and methionine deficiency. These findings indicate that arginine-mediated cell growth or survival and activation of mTOR signaling are not specific and reflect the essentiality of arginine and methionine for protein synthesis. However, the dependence of the cell protein synthesis response on arginine, and not on methionine, suggests that arginine may be firstlimiting for this cell function. These results are consistent with the finding that mTOR is a vital effector protein in the cell stress response produced by removal of essential amino acids, especially arginine (16) . Deprivation of methionine and other essential amino acids activates cell stress signals, in addition to mTOR, that activate further-downstream signals and gene transcription (17, 30) . Our results suggest that suppression of mTOR by essential amino acid deprivation is important, not only for protein synthesis, but also for cell survival; yet the downstream signals involved in this response are unknown.
Besides its role in protein synthesis, arginine is also a precursor for two key molecules involved in cell function, NO and ornithine, synthesized via NOS and arginase enzymes, respectively. NO plays a key role in several cell functions and activates guanylyl cyclase and production of cGMP, which then acts as a signaling molecule to stimulate various cell kinases and transcription factors (23) . Ornithine is a precursor for polyamines, which are essential for cell proliferation and growth (43) . Our results suggest that NO does not play a significant role in the arginine-induced stimulation of protein synthesis in IPEC-J2 cells. Neither NOS inhibitor (L-NAME nor aminoguanidine) affected the arginine-induced stimulation of protein synthesis across a wide range of concentrations, despite the presence of iNOS in IPEC-J2 cells. However, IPEC-J2 cells have a limited capacity for iNOS-mediated NO production, since we found no increase in media total nitrite concentration in the presence of 0.5 mM arginine. Thus we also treated cells with the NO donor SNAP and verified NO production in the cell medium. Although SNAP treatment increased NO, the increased NO availability failed to activate protein synthesis in the absence of arginine. Instead, it tended to suppress protein synthesis, especially at the highest dose. In addition, the presence of SNAP significantly decreased p70 S6 kinase and 4E-BP1 activation in the absence of arginine. Collectively, our results suggest that NO impairs IPEC-J2 cell protein synthesis, which implies that the arginine-induced stimulation of protein synthesis is NO-independent in IPEC-J2 cells. These findings are in contrast to a recent study in cdx2-transformed rat crypt IEC-6 cells in which arginine and an NO donor stimulated IEC migration and p70 S6 kinase phosphorylation (26) . This suggests that IEC migration and protein synthesis response to arginine are activated by different signaling pathways. Whether NO is involved in the arginine- induced protein synthesis in other IEC with more robust NOS activity remains to be tested.
To further examine the essentiality of arginine, we incubated arginine-deprived IPEC-J2 cells with citrulline and proline, which are arginine precursors in neonatal piglets (34, 36) . Surprisingly, neither affected protein synthesis, nor did we find any significant arginine produced from proline or citrulline in IPEC-J2 cells. The lack of arginine synthesis in IPEC-J2 cells was explained by the markedly lower activity of the enzymes, specifically ASS, ASL, and P5CS, involved in arginine synthesis from these precursors. Also, the finding that arginase activity was an order of magnitude higher in IPEC-J2 cells than in pig primary IEC would prevent the production of arginine, since this enzyme catalyzes the conversion of arginine to ornithine. These findings clearly indicate that IPEC-J2 cells, originally derived from newborn piglets, do not have the capacity to synthesize arginine. This is in contrast to previous studies showing that primary IEC isolated from newborn pigs are capable of arginine synthesis from proline and citrulline (37, 41) .
Finally, we showed that the arginine-induced increase in protein synthesis was maximally inhibited by ϳ42% over a wide range of rapamycin concentrations (1-1,000 nM). Moreover, the arginine-induced increase in IPEC-J2 cell survival was partially inhibited (Ϫ30%) by rapamycin after 2 days of incubation. These results suggest that part of the arginine effect is rapamycin insensitivity. mTOR exists in two protein complexes, namely, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (7) . mTORC1 is considered the master regulator of protein synthesis; it is rapamycin-sensitive and consists of mTOR, raptor, and G protein ␤-subunit-like protein (G␤L). This complex is known to be activated by amino acids, hormones/growth factors, and energy signals (18) . In contrast, mTORC2 is rapamycin-insensitive and consists of mTOR, rictor, and G␤L (7) and activates protein kinase B, a key regulator of cell survival upstream to mTORC1 (28) . Previous studies with IEC and cultured porcine intestinal tissue explants showed that rapamycin treatment blocks the arginine-induced activation of p70 S6 kinase and 4E-BP1 (6, 27) . However, although our treatment with rapamycin significantly reduced mTOR and 4E-BP1 activation, we were surprised to find no effect of rapamycin on p70 S6 kinase activation, which may be explained by the high variation between the samples. Rapamycin forms a complex with its intracellular receptor FKBP12 (12-kDa FK 506-binding protein), which then binds to the FRB (FKBP12-rapamycin binding) domain of mTOR and inhibits mTORC1 signaling through a poorly understood mechanism (5). However, recent reports suggest a relative inefficacy of rapamycin and rapalogs (rapamycin analogs) in cancer treatment attributed to hyperactivation of Akt (upstream of mTOR) through loss of the mTORC1-p70 S6 kinase-insulin receptor substrate-1-phosphoinositide 3-kinase negative-feedback loop (8). In addition, recent studies suggest that mTORC1 exhibits rapamycin-sensitive and -insensitive activities (10, 33) . Taken together, these findings suggest that the "partial effect" of rapamycin on arginine-induced protein synthesis may be due to the fact that rapamycin does not completely inhibit the mTORC1 signaling pathway. Several novel active-site mTOR kinase inhibitors, which inhibit mTORC1 and mTORC2, were recently developed (8) . Nevertheless, the rapamycin-sensitive effect on arginine-dependent cell survival reinforces the point that mTOR signaling is vital for IEC cycle function.
In summary, our results from a porcine IEC line (IPEC-J2) demonstrate that arginine is required for cell survival and protein synthesis and that the maximal response occurs in the physiological concentration range. In addition, arginine increased the activation of mTOR, p70 S6 kinase, and 4E-BP1 in a time-and dose-dependent manner. Moreover, the arginineinduced protein synthesis response was not affected by NOS inhibitors, such as L-NAME and aminoguanidine, or the presence of the NO donor SNAP. We also determined that IPEC-J2 cells, in contrast to primary pig IEC, have a lower capacity to synthesize arginine, partly due to a markedly higher arginase activity, and this likely explains why it is required for IPEC-J2 cell survival. Furthermore, rapamycin, which is not a complete inhibitor of mTOR, partially reduced the arginine-induced protein synthesis response. Thus we conclude that arginineinduced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but does not involve NO or insulin. The intracellular signals that mediate the effect of arginine on the activation of mTOR, protein synthesis, and cell survival in IEC warrant further study. Values (means Ϯ SE) are expressed as percentage of control (0 nM rapamycin). B: cell growth response, i.e., cell count, to arginine and/or rapamycin in IPEC-J2 cells incubated for 2 days in arginine-free DMEM in the presence or absence of 0.5 mM arginine and 10 nM rapamycin. C: activation response of mTOR, p70 S6 kinase, and 4E-BP1 to arginine and/or rapamycin in IPEC-J2 cells incubated for 1 h in arginine-free DMEM in the presence or absence of 0.5 mM arginine or 10 nM rapamycin, as determined by Western blot analysis of phosphorylated (Ser 2448 ) mTOR, phosphorylated (Thr 421 /Ser 424 ) p70 S6 kinase, and phosphorylated (Thr 70 ) 4E-BP1 expression relative to their respective total protein expression. Values (means Ϯ SE) are expressed as percentage of control (no arginine-no rapamycin) in A and C. *P Ͻ 0.001 vs. no arginine-no rapamycin, † P Ͻ 0.001 vs. 0.5 mM arginine-no rapamycin; #P Ͻ 0.05 vs. 0.5 mM arginine-0.1 nM rapamycin in A. **P Ͻ 0.01, ***P Ͻ 0.001 vs. T0 in B. *P Ͻ 0.05 vs. no arginine-no rapamycin in C. Main effect of rapamycin and arginine ϫ rapamycin interaction for mTOR (P Ͻ 0.05) and 4E-BP1 (P Ͻ 0.05) based on 2-way ANOVA.
